Last December 2013 I asked Gerald at the Conferenc
Post# of 30028
Posted On: 10/11/2014 12:27:45 PM
Last December 2013 I asked Gerald at the Conference in L.A. if "shareholders would be happy by February." At that time we needed to get above .10 cents for 20 consecutive days in order to get the 5 or 10 million warrant money we needed to keep things going. Gerald responded, "Oh, we'll be in great shape by the U.N. Conference at the end of January." He further said they had a lot of catalysts coming after the first of the year.
It is true, in the first half of January the pps did spike up to .138 cents due to our anticipation of a LymPro Partnership. Many of us were expecting a JV partnership for Lympro with large up front money. Back in Sept of 2013 Gerald told me in Las Vegas regarding our LymPro partner: "Someone might pay you x now, but down the road be willing to pay you 100x." That is where I first got the notion of a "classic partner" for Lympro with up front money.
But at the SF Conference on January 15th, Gerald announced we had discovered some "codes" for reimbursement that would increase LymPro's net present value many times. And as a result, we would not be pursuing a Lympro partner in the immediate future. The stock price immediately started falling from .138 cents to below .07 cents. (Yet, I have never heard Gerald refer to these important codes since that occasion, nor seen the increase in net present value!)
The pps remained low until May when Gerald announced they had "identified" a Lympro partner but were still finalizing the details and wouldn't announcement the agreement until after the July Conferences in order to gain additional "leverage." The pps went from .07 cents to .193 cents on July 30th in anticipation of the LymPro data that preceded the LymPro partnership announcement. We all know what happened on July 31st. We dropped from .193 cents to .12 cents.
In August we held out hope for the LymPro data and the JV partnership announcement in September, the "end of summer." Instead, we got a master service agreement with ICON instead of a "classic partner" and the pps fell from .12 cents down to the .087 cents where we are now.
So, with all that said, many of us feel Gerald has left us at the altar a few times this year and as a result....feel anxiety over his promises that have managed to elusively slip away. During 2014.... we started at around .08 or .09 cents, and after many fits and starts....we are still there. So I would ask the people on the board who frequently lecture some of us longs that have criticisms....to be patient with us. Some of us are in a position where our investment is maybe larger than it should be for our overall net worth. As a result, we do care about the near term pps, not just what AMbS will be worth in 4 or 5 years. Please be patient with us and not lecture us about being over invested in this high risk stock. There are all sorts of people and situations and reasons why people invest the way they do.
The concerns I have raised this past month, and that JP has raised recently, and others as well, are not because we are flippers like Solantey, it is because we have genuine concerns. It doesn't mean we aren't solidly with you in our love of Gerald and belief in AMBS. We just have different expectations and time frames than you do.
Obviously, I sometimes get emotional and overstate things. I apologize for that. I will try to reign in the intensity. But my posts have been genuine. If dissenting and contrary views are presented on this board, in a polite way, they should be treated respectfully. I'll try not to call people names, if in return I am not belittled in posts attacking my concerns. It goes both ways.
I have been in stocks before that showed great promise, but never went anywhere. That is what happens in small biomed penny stocks. By the way, that is what we are! We're not Amgen yet. There are no guarantees that everything will turn out the way Gerald promises. They haven't so far. Many CEO's go down in flames trying to build their fledgling companies. So for those who are smug about AMBS' inevitability and like to lecture us who lack faith and like to question things....I ask that you not be so smug. You don't know but what our concerns may be valid. And the message board is the appropriate place to discuss them...civilly.
It is true, in the first half of January the pps did spike up to .138 cents due to our anticipation of a LymPro Partnership. Many of us were expecting a JV partnership for Lympro with large up front money. Back in Sept of 2013 Gerald told me in Las Vegas regarding our LymPro partner: "Someone might pay you x now, but down the road be willing to pay you 100x." That is where I first got the notion of a "classic partner" for Lympro with up front money.
But at the SF Conference on January 15th, Gerald announced we had discovered some "codes" for reimbursement that would increase LymPro's net present value many times. And as a result, we would not be pursuing a Lympro partner in the immediate future. The stock price immediately started falling from .138 cents to below .07 cents. (Yet, I have never heard Gerald refer to these important codes since that occasion, nor seen the increase in net present value!)
The pps remained low until May when Gerald announced they had "identified" a Lympro partner but were still finalizing the details and wouldn't announcement the agreement until after the July Conferences in order to gain additional "leverage." The pps went from .07 cents to .193 cents on July 30th in anticipation of the LymPro data that preceded the LymPro partnership announcement. We all know what happened on July 31st. We dropped from .193 cents to .12 cents.
In August we held out hope for the LymPro data and the JV partnership announcement in September, the "end of summer." Instead, we got a master service agreement with ICON instead of a "classic partner" and the pps fell from .12 cents down to the .087 cents where we are now.
So, with all that said, many of us feel Gerald has left us at the altar a few times this year and as a result....feel anxiety over his promises that have managed to elusively slip away. During 2014.... we started at around .08 or .09 cents, and after many fits and starts....we are still there. So I would ask the people on the board who frequently lecture some of us longs that have criticisms....to be patient with us. Some of us are in a position where our investment is maybe larger than it should be for our overall net worth. As a result, we do care about the near term pps, not just what AMbS will be worth in 4 or 5 years. Please be patient with us and not lecture us about being over invested in this high risk stock. There are all sorts of people and situations and reasons why people invest the way they do.
The concerns I have raised this past month, and that JP has raised recently, and others as well, are not because we are flippers like Solantey, it is because we have genuine concerns. It doesn't mean we aren't solidly with you in our love of Gerald and belief in AMBS. We just have different expectations and time frames than you do.
Obviously, I sometimes get emotional and overstate things. I apologize for that. I will try to reign in the intensity. But my posts have been genuine. If dissenting and contrary views are presented on this board, in a polite way, they should be treated respectfully. I'll try not to call people names, if in return I am not belittled in posts attacking my concerns. It goes both ways.
I have been in stocks before that showed great promise, but never went anywhere. That is what happens in small biomed penny stocks. By the way, that is what we are! We're not Amgen yet. There are no guarantees that everything will turn out the way Gerald promises. They haven't so far. Many CEO's go down in flames trying to build their fledgling companies. So for those who are smug about AMBS' inevitability and like to lecture us who lack faith and like to question things....I ask that you not be so smug. You don't know but what our concerns may be valid. And the message board is the appropriate place to discuss them...civilly.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼